UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.462

Sortiert nach

Ten‐year update of the international registry on cytokine‐induced killer cells in cancer immunotherapy

Journal of cellular physiology, 2020-12, Vol.235 (12), p.9291-9303

2020

Volltextzugriff (PDF)

30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective

Journal of experimental & clinical cancer research, 2021-12, Vol.40 (1), p.388-388, Article 388

2021

Volltextzugriff (PDF)

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2007-05, Vol.356 (22), p.2271-2281

2007

Volltextzugriff (PDF)

Non-viral and hybrid vectors in human gene therapy: an update

Trends in molecular medicine, 2003-02, Vol.9 (2), p.67-72

2003

Volltextzugriff (PDF)

Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)

Journal of cancer research and clinical oncology, 2015-05, Vol.141 (5), p.839-849

2015

Volltextzugriff (PDF)

PD‑1 blockade enhances cytokine‑induced killer cell‑mediated cytotoxicity in B‑cell non‑Hodgkin lymphoma cell lines

Oncology letters, 2021-08, Vol.22 (2), p.1, Article 613

2021

Volltextzugriff (PDF)

Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy

International journal of molecular sciences, 2019-09, Vol.20 (17), p.4307

2019

Volltextzugriff (PDF)

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)

Journal of cancer research and clinical oncology, 2011-02, Vol.137 (2), p.305-310

2011

Volltextzugriff (PDF)

Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer

Molecular cancer, 2024-04, Vol.23 (1), p.80-80, Article 80

2024

Volltextzugriff (PDF)

The elusive effect of water and sanitation on the global burden of disease

Tropical medicine & international health, 2014-05, Vol.19 (5), p.522-527

Schmidt, Wolf‐Peter

2014

Volltextzugriff (PDF)

Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5626

2023

Volltextzugriff (PDF)

Women's role in sanitation decision making in rural coastal Odisha, India

PloS one, 2017-05, Vol.12 (5), p.e0178042-e0178042

2017

Volltextzugriff (PDF)

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer

International journal of molecular sciences, 2020-04, Vol.21 (9), p.3078

2020

Volltextzugriff (PDF)

Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer

Journal of experimental & clinical cancer research, 2024-03, Vol.43 (1), p.71-71, Article 71

2024

Volltextzugriff (PDF)

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

Leukemia, 2015-08, Vol.29 (8), p.1721-1729

2015

Volltextzugriff (PDF)

How shared is decision‐making in multidisciplinary tumour conferences with patient participation? An observational study

Health expectations : an international journal of public participation in health care and health policy, 2022-12, Vol.25 (6), p.3297-3306

2022

Volltextzugriff (PDF)

Systematic integration of m6A regulators and autophagy-related genes in combination with long non-coding RNAs predicts survival in glioblastoma multiforme

Scientific reports, 2023-10, Vol.13 (1), p.17232-17232, Article 17232

2023

Volltextzugriff (PDF)

Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment

BMC medical genomics, 2023-11, Vol.16 (1), p.295-295, Article 295

2023

Volltextzugriff (PDF)

RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group

Journal of clinical oncology, 2011-04, Vol.29 (10), p.1364-1372

2011

Volltextzugriff (PDF)

EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC

Cancers, 2020-10, Vol.12 (10), p.3019

2020

Volltextzugriff (PDF)

Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome

BMC cancer, 2020-04, Vol.20 (1), p.355-355, Article 355

2020

Volltextzugriff (PDF)

Improvements in Flow Cytometry‐Based Cytotoxicity Assay

Cytometry. Part A, 2021-07, Vol.99 (7), p.680-688

2021

Volltextzugriff (PDF)

Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma

International journal of molecular sciences, 2023-08, Vol.24 (15), p.12476

2023

Volltextzugriff (PDF)

1 – 25 von 3.462

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.294)
Mit Volltextzugriff
(3.133)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(2.402)
Deutsch
(1.086)
Japanisch
(245)
Französisch
(4)
Norwegisch
(1)
Russisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.517)
Life Sciences & Biomedicine
(1.077)
Humans
(859)
Male
(473)
Female
(461)
Literary Studies: From C 1900
(376)
Physical Sciences
(372)
Literary Studies: C 1500 To C 1800
(352)
Literature: History & Criticism
(352)
Middle Aged
(319)
Biological And Medical Sciences
(296)
Adult
(286)
Physics
(280)
Aged
(266)
Medical Sciences
(239)
Animals
(222)
Oncology
(218)
Technology
(191)
Chemistry
(133)
Hematology
(126)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(77)
Physical Review Letters
(45)
Journal Of Clinical Oncology
(38)
Anticancer Research
(22)
Nuclear Physics. A
(22)
Annals Of Hematology
(19)
Annals Of Oncology
(19)
Journal Of Physics. Conference Series
(19)
Stroke
(19)
Plos One
(18)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Ten‐year update of the international registry on cytokine‐induced killer cells in cancer immunotherapy

30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

Non-viral and hybrid vectors in human gene therapy: an update

Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)

PD‑1 blockade enhances cytokine‑induced killer cell‑mediated cytotoxicity in B‑cell non‑Hodgkin lymphoma cell lines

Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)

Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer

The elusive effect of water and sanitation on the global burden of disease

Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

Women's role in sanitation decision making in rural coastal Odisha, India

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer

Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

How shared is decision‐making in multidisciplinary tumour conferences with patient participation? An observational study

Systematic integration of m6A regulators and autophagy-related genes in combination with long non-coding RNAs predicts survival in glioblastoma multiforme

Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment

RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group

EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome

Improvements in Flow Cytometry‐Based Cytotoxicity Assay

Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma

Suchergebnisse filtern